Status:
UNKNOWN
Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Lead Sponsor:
Peking University Cancer Hospital & Institute
Conditions:
QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to explore the influence of neoadjuvant chemotherapy in the long term quality of life with advanced gastric cancer patients.
Detailed Description
Preoperative adjuvant chemotherapy combined with postoperative adjuvant therapy mode was included in the 2018 version of the National Comprehensive Cancer Network (NCCN) guideline as an optional treat...
Eligibility Criteria
Inclusion
- Patients age older than 18 years (including 18 years old);
- Diagnosis of adenocarcinoma of the stomach
- The clinic stage is ≥T2 and any N stage
- Patient had curative surgical resection, including proximal, distal, or total gastrectomy
Exclusion
- Psychiatric or psychological abnormality precluding informed consent or ability to complete questionnaires
- Non-psychiatric disorder causing a lack of capacity to give consent or an inability to complete questionnaires (ie dementia, stroke)
- Early gastric cancer.
Key Trial Info
Start Date :
April 17 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 10 2022
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT04408859
Start Date
April 17 2018
End Date
January 10 2022
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100010